Bioorganic and Medicinal Chemistry Letters p. 3123 - 3126 (1999)
Update date:2022-08-04
Topics:
Yoshida, Yoshiki
Matsuda, Keiji
Sasaki, Hiroshi
Matsumoto, Yoshimi
Matsumoto, Satoru
Takasugi, Hisashi
The synthesis and anti-Helicobacter pylori activity of a novel cephem derivative FR182024 (1) are described. FR182024 having a (5-methyl-1,3,4-thiadiazol-2-yl)-thio moiety at the 3-position and a phenylacetamido at the 7-position was found to have extremely potent in vitro anti-H.pylori activity, superior therapeutic efficacy to AMPC and CAM, and low potential for causing diarrhea.
View MoreGUANGZHOU MEDCAN PHARMATECH LTD
website:http://www.gzmedcan.com
Contact:+86-20-82519649
Address:Building J,Room 101,1 JiangtashanRd,Guang Zhou Science City,Guang Zhou ,China
Hangzhou Neway Chemicals Co., Ltd.
Contact:+86-571-85095566
Address:Room 803, Qinglian Bldg, No 139 Qingchun Road, Hangzhou, Zhejiang China
Shenzhen Feiming Science and Technology Co,. Ltd
Contact:+86-755-85232577
Address:#B2309, Fenglin International Center ,Jixiang Road, Longcheng street, LongGang District, Shenzhen city, Guangdong province, China.
Contact:+86-579-85206992
Address:No 451 chouzhou north road ,room 1106 int'l business center , yiwu ,china
Chemsky（shanghai）International Co.,Ltd.
Contact:0
Address:0
Doi:10.1016/0031-9422(96)00242-7
(1996)Doi:10.1039/b912325c
(2009)Doi:10.1016/0020-1650(68)80164-3
(1968)Doi:10.1016/S0022-328X(96)87021-5
(1996)Doi:10.1007/BF00702025
()Doi:10.1039/dt9960002541
(1996)
